|
Q3 FY2026
As of Jul 31, 2026
|
Q2 FY2026
As of Apr 30, 2026
|
Q1 FY2026
As of Jan 31, 2026
|
Q4 FY2025
As of Oct 31, 2025
|
Q3 FY2025
As of Jul 31, 2025
|
Q2 FY2025
As of Apr 30, 2025
|
Q1 FY2025
As of Jan 31, 2025
|
Q4 FY2024
As of Oct 31, 2024
|
Q3 FY2024
As of Jul 31, 2024
|
Q2 FY2024
As of Apr 30, 2024
|
Q1 FY2024
As of Jan 31, 2024
|
Q4 FY2023
As of Oct 31, 2023
|
Q3 FY2023
As of Jul 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current Assets | |||||||||||||
| Accrued interest receivable | |||||||||||||
| Due from related party | |||||||||||||
| Cash | |||||||||||||
| Accounts receivable | |||||||||||||
| Prepaid payroll | |||||||||||||
| Other receivable | |||||||||||||
| Total Current Assets | |||||||||||||
| Non-Current Assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Long term asset, net | |||||||||||||
| Right-of-use asset | |||||||||||||
| Security deposits | |||||||||||||
| Total Non-Current Assets | |||||||||||||
| TOTAL ASSETS | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||||
| LIABILITIES | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued payroll | |||||||||||||
| Accrued interest | |||||||||||||
| Lease liability | |||||||||||||
| Payroll tax | |||||||||||||
| Advances, related party | |||||||||||||
| Customer deposits | |||||||||||||
| Lease vendor payable | |||||||||||||
| Convertible note payable, at fair value | |||||||||||||
| Convertible notes payable, net of discounts and issue costs | |||||||||||||
| Notes payable, related party | |||||||||||||
| Derivative liability | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Non-Current Liability | |||||||||||||
| Lease liability | |||||||||||||
| Long term notes payable, related party | |||||||||||||
| Total Non-Current Liability | |||||||||||||
| Total Liabilities | |||||||||||||
| STOCKHOLDERS’ DEFICIT | |||||||||||||
| Preferred stock, value | |||||||||||||
| Series A Preferred Stock | |||||||||||||
| Series B Preferred Stock | |||||||||||||
| Common stock, par value $0.001 per share; 985,000,000 shares authorized; 102,355,323 and 100,795,491 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively | |||||||||||||
| Common stock payable | |||||||||||||
| Common stock subscription receivable | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Stockholders’ Deficit | |||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...
